9-Me-BC
Also known as: 9-Me-BC, 9-Methyl-beta-carboline
9-Me-BC (9-methyl-beta-carboline) is a small-molecule beta-carboline studied as a nootropic for its dopaminergic, neuroprotective, and neurogenesis-promoting effects in animal models.
Last updated
Mechanism of Action
9-Me-BC is a beta-carboline alkaloid that acts as a mild monoamine oxidase inhibitor and increases dopaminergic activity, raising dopamine levels in the brain. In cell and rodent studies it stimulates the proliferation and maturation of dopaminergic neurons, upregulates neurotrophic factors, and exerts anti-inflammatory effects on glial cells. These combined actions are studied for cognitive enhancement and protection of dopaminergic systems relevant to learning and Parkinsonian models.
- Half-life
- Not well characterized in humans; estimated several hours
- Administration Routes
- oral
- Research Status
- Research Chemical
Reported Benefits
- Studied for increased dopaminergic activity
- May support cognition, focus, and motivation in research models
- Promotes dopaminergic neuron growth in preclinical studies
- Investigated for neuroprotective and anti-inflammatory effects
- Explored for mood and drive enhancement
Potential Side Effects
- Possible overstimulation or insomnia from dopaminergic effects
- Headache
- Potential interactions with other monoamine-affecting compounds
- Limited human safety data; some genotoxicity questions raised for beta-carbolines
Common Dosing
Characterized only in preclinical/animal research; no validated human protocol exists, and figures circulating online are anecdotal rather than research-grade. For laboratory research use only.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Concurrent use of MAO inhibitors or serotonergic drugs
- Pregnancy or breastfeeding
- Not for human or clinical use
Noopept
A synthetic dipeptide-derived nootropic developed in Russia, structurally related to the racetam family. It is studied for memory, learning and neuroprotective effects at very low milligram doses.
Bromantane
Bromantane is an adamantane-derived actoprotector with mild stimulant and anxiolytic properties, used clinically in Russia (as Ladasten) for asthenia and fatigue. It is a small-molecule research chemical, not a peptide, in most other markets. Note: Bromantane is a small-molecule actoprotector, not a peptide, though it is often catalogued with research peptides.
- View
9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation
2012
- View
The exceptional properties of 9-methyl-beta-carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects
2010
- View
9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease
2010
- View
9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes
2020
- View
Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?
2011